The pharmaceutical company on Friday announced that it has appointed Srinivas Sadu as executive chairman and chief executive officer (CEO) of the company, with effect from 10 June 2024.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
